LENZ Therapeutics (NASDAQ:LENZ) Price Target Raised to $47.00
LENZ Therapeutics (NASDAQ:LENZ – Free Report) had its price target increased by Citigroup from $44.00 to $47.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have a buy rating on the stock. Separately, TD Cowen assumed coverage on LENZ Therapeutics in a research note on Tuesday, March 18th. They set a […]
LENZ Therapeutics (NASDAQ:LENZ – Free Report) had its price target increased by Citigroup from $44.00 to $47.00 in a research report sent to investors on Thursday,Benzinga reports. They currently have a buy rating on the stock. Separately, TD Cowen assumed coverage on LENZ Therapeutics in a research note on Tuesday, March 18th. They set a […]
